Literature DB >> 26520216

Acceptance and Commitment Therapy in the Treatment of Alcohol Use Disorder and Comorbid Affective Disorder: A Pilot Matched Control Trial.

Thekiso B Thekiso1, Philip Murphy1, Jennie Milnes1, Kathryn Lambe1, Aisling Curtin1, Conor K Farren2.   

Abstract

This study examined whether acceptance and commitment therapy (ACT) enhances treatment as usual (TAU) in improving treatment outcomes in patients with alcohol use disorder (AUD) and comorbid affective disorder. Fifty-two participants were included in the study, of whom 26 were patients with AUD and either depression or bipolar disorder treated with ACT group therapy in parallel with TAU (inpatient integrated treatment) and 26 were matched controls who had received TAU alone. Drinking and craving outcomes were total alcohol abstinence, cumulative abstinence duration (CAD) and Obsessive Compulsive Drinking Scale (OCDS) scores at 3 and 6 months postintervention. Affective and anxiety outcomes were Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) and Young Mania Rating Scale (YMRS) scores at these follow-ups. Baseline demographic and clinical characteristics were similar in both groups. Retention rates were high: 100% of the ACT group were followed up at 3 and 6 months; 92.3% and 84.6% of the TAU alone group were followed up at 3 and 6 months, respectively. Patients in the ACT group reported significantly higher CAD at 3 and 6 months, significantly lower BDI and BAI scores at 3 and 6 months, and significantly lower OCDS scores at 3 months, than those who received only TAU. No other significant differences in treatment outcomes were found between the groups. ACT provides added benefit to TAU in improving drinking, craving, depression and anxiety outcomes in patients with AUD and comorbid affective disorder. Most treatment improvements were sustained over a 6-month follow-up period.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  acceptance and commitment therapy; affective disorder; alcohol use disorder; bipolar disorder; depression

Mesh:

Year:  2015        PMID: 26520216     DOI: 10.1016/j.beth.2015.05.005

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  7 in total

1.  Analgesic reduction during an interdisciplinary pain management programme: treatment effects and processes of change.

Authors:  Beth J Guildford; Aisling Daly-Eichenhardt; Bethany Hill; Karen Sanderson; Lance M McCracken
Journal:  Br J Pain       Date:  2017-10-02

2.  Acceptance and Commitment Therapy (ACT) for HIV-infected Hazardous Drinkers: A Qualitative Study of Acceptability.

Authors:  Sarah E Woolf-King; Alan Z Sheinfil; Jacklyn D Babowich; Bob Siedle-Khan; Amanda Loitsch; Stephen A Maisto
Journal:  Alcohol Treat Q       Date:  2018-11-08

3.  The Role of Affect in Psychosocial Treatments for Substance Use Disorders.

Authors:  Julia E Swan; Victoria R Votaw; Elena R Stein; Katie Witkiewitz
Journal:  Curr Addict Rep       Date:  2020-06-01

4.  Development of a Telephone-Delivered Acceptance and Commitment Therapy Intervention for People Living with HIV who are Hazardous Drinkers.

Authors:  Sarah E Woolf-King; Madison Firkey; Jacklyn D Foley; Jonathan Bricker; Judith A Hahn; Elizabeth Asiago-Reddy; John Wikier; Dezarie Moskal; Alan Z Sheinfil; Jeremy Ramos; Stephen A Maisto
Journal:  AIDS Behav       Date:  2022-03-18

5.  Exploring the feasibility and acceptability of a recovery-focused group therapy intervention for adults with bipolar disorder: trial protocol.

Authors:  Alison K Beck; Amanda Baker; Steven Jones; Fiona Lobban; Frances Kay-Lambkin; John Attia; Michelle Banfield
Journal:  BMJ Open       Date:  2018-01-31       Impact factor: 2.692

6.  Internet-based self-help smoking cessation and alcohol moderation interventions for cancer survivors: a study protocol of two RCTs.

Authors:  Ajla Mujcic; Matthijs Blankers; Brigitte Boon; Rutger Engels; Margriet van Laar
Journal:  BMC Cancer       Date:  2018-04-02       Impact factor: 4.430

7.  "I don't want to take buprenorphine for the rest of my life": Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design).

Authors:  Kate Shepherd; Beth Pritty; Anna Tickle; Nima Moghaddam
Journal:  Int J Ment Health Addict       Date:  2021-12-20       Impact factor: 3.836

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.